Medical cannabis provides little improvement to sleep in chronic pain patients
1. In this systematic review and meta-analysis, medical cannabis and cannabinoids versus placebo...
Read More
Oncology
No observed benefit of adjuvant everolimus combined with endocrine therapy for hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer
1. Disease-free survival did not differ significantly between patient groups and overall survival...
Read More
Neoadjuvant nivolumab with chemotherapy increases survival in resectable non-small-cell lung cancer
1. Neoadjuvant nivolumab plus chemotherapy led to a longer event-free survival and higher...
Read More
Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
1. 5-year progression-free status was greatest in group 3 (triple therapy) and lowest in group 1...
Read More
Tiragolumab with atezolizumab is a promising treatment option for PD-L1 positive advanced non-small-cell-lung cancer
1. Progression-free survival was longer for patients receiving tiragolumab with atezolizumab as...
Read More
Adebrelimab plus chemotherapy improves overall survival in extensive-stage small-cell lung cancer
1. The adebrelimab group had an improved overall survival, higher objective response rate and an...
Read More
#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
Click to read this study in Journal of Clinical Oncology.
Read More
Imiquimod noninferior to surgery in management of vulvar high-grade squamous intraepithelial lesions
1. Complete clinical response at 6 months was similar in both the topical imiquimod and surgery...
Read More
The antibody drug conjugate MRGOO3 is a promising for use in EGFR-expressing cancers
1. The median progression free survival for all cancer-types was 2.8 months. 2. Most of the...
Read More
Abiraterone plus prednisone improves survival in patients with de novo metastatic castration-sensitive prostate cancer
1. A combination of androgen deprivation therapy, docetaxel, and abiraterone (“triplet therapy”)...
Read More
Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer
1. Patients with resectable non-small cell lung cancer (NSCLC) receiving neoadjuvant nivolumab in...
Read More
Treatment with chemoradiotherapy before systemic chemotherapy for rectal adenocarcinoma is a potential non-surgical option
1. Disease-free survival was not impacted by the order in which chemoradiotherapy CRT and systemic...
Read More
#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma
Click to read this study in The Lancet Oncology.
Read More
Support for Liver Cancer at ASCO 2022
Liver cancer is the third-highest cause of cancer-related deaths worldwide, and incidence of...
Read More
Increases in muscle-strengthening activities may reduce mortality risk and certain diseases
1. Muscle-strengthening activities (MSA) were associated with a lower risk of cardiovascular...
Read More
#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in premenopausal women with ER+ breast cancer and ovarian suppression
Click to read this study in The Lancet Oncology.
Read More
Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer
1. Patients who underwent segmentectomy reported a significantly greater 5-year overall survival...
Read More